Please use this identifier to cite or link to this item: http://adhlui.com.ui.edu.ng/jspui/handle/123456789/2069
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNZEH, D. A-
dc.contributor.authorERASMUS, R. T-
dc.contributor.authorAIYEDUN, B. A-
dc.date.accessioned2024-07-05T12:08:47Z-
dc.date.available2024-07-05T12:08:47Z-
dc.date.issued1994-03-
dc.identifier.citationAfr. J. Med. med. Sci. (1994) 23, 35-37en_US
dc.identifier.issn1116-4077-
dc.identifier.urihttp://adhlui.com.ui.edu.ng/jspui/handle/123456789/2069-
dc.descriptionArticleen_US
dc.description.abstractSerum electrolyte and protein changes in 35 Nigerian patients undergoing intravenous urography were evaluated after injection of 60 mis sodium and meglumine diatrizoate (Urograffin-370). Statistically, significant changes were noted in the values of serum calcium, proteins and albumin at 5 'and 30 minutes after the injection (P < 0.005). The mean percentage decreases noted were calcium 13%, protein 17% and albumin 13%. At 30 minutes post-injection, the serum protein and albumin levels had incompletely recovered while calcium values continued to decrease. Non-statistically, significant changes were observed in the values of serum sodium, potassium and phosphate at 5 and 30 minutes respectively following contrast medium injection. Alterations in the levels of scrum electrolytes especially calcium are most probably responsible for such adverse effects as convulsions and cardiac arrhythmias.en_US
dc.description.sponsorshipCollege of medicineen_US
dc.language.isoenen_US
dc.publisherSpectrum Books Limiteden_US
dc.subjectSerumen_US
dc.subjectproteinen_US
dc.subjectcalciumen_US
dc.subjectinjectionen_US
dc.titleSerum electrolyte and protein changes after intravenous injection of sodium and meglumine diatrizoate (urograffin - 370)en_US
dc.typeArticleen_US
Appears in Collections:African Journal of Medicine and Medical Sciences

Files in This Item:
File Description SizeFormat 
Nzeh et al_Serum-1994.pdfArticle8.82 MBAdobe PDFView/Open


Items in COMUI (ADHL) are protected by copyright, with all rights reserved, unless otherwise indicated.